CN102362865B - 一种含有盐酸贝尼地平和缬沙坦的复方制剂及其应用 - Google Patents
一种含有盐酸贝尼地平和缬沙坦的复方制剂及其应用 Download PDFInfo
- Publication number
- CN102362865B CN102362865B CN 201110332869 CN201110332869A CN102362865B CN 102362865 B CN102362865 B CN 102362865B CN 201110332869 CN201110332869 CN 201110332869 CN 201110332869 A CN201110332869 A CN 201110332869A CN 102362865 B CN102362865 B CN 102362865B
- Authority
- CN
- China
- Prior art keywords
- weight portions
- valsartan
- preparation
- magnesium stearate
- compound preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110332869 CN102362865B (zh) | 2011-10-28 | 2011-10-28 | 一种含有盐酸贝尼地平和缬沙坦的复方制剂及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110332869 CN102362865B (zh) | 2011-10-28 | 2011-10-28 | 一种含有盐酸贝尼地平和缬沙坦的复方制剂及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102362865A CN102362865A (zh) | 2012-02-29 |
CN102362865B true CN102362865B (zh) | 2013-06-26 |
Family
ID=45689482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110332869 Active CN102362865B (zh) | 2011-10-28 | 2011-10-28 | 一种含有盐酸贝尼地平和缬沙坦的复方制剂及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102362865B (zh) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2333757C2 (ru) * | 2000-06-22 | 2008-09-20 | Новартис Аг | Фармацевтические композиции |
CN102166212A (zh) * | 2003-06-17 | 2011-08-31 | 协和发酵麒麟株式会社 | 使盐酸贝尼地平从片剂中迅速溶出的方法 |
-
2011
- 2011-10-28 CN CN 201110332869 patent/CN102362865B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102362865A (zh) | 2012-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kovesdy | Management of hyperkalemia: an update for the internist | |
CN103751193B (zh) | 包含利拉列汀和任选的sglt2抑制剂的药物组合物及其用途 | |
JP2011528669A (ja) | 高血圧と代謝症候群の治療に用いられる薬物組成物及びその応用 | |
CN101406472A (zh) | 阿替洛尔/氨氯地平/叶酸类化合物的药物组合物及其用途 | |
Brown et al. | Drug interactions with digoxin | |
CN101966189A (zh) | 一种治疗高血压含氨氯地平和奥美沙坦的复方制剂 | |
JP2018135278A (ja) | 循環器疾患及び/又はミトコンドリア病の改善用医薬 | |
CN101229373B (zh) | 治疗糖尿病肾病的药物组合物 | |
CN101229372B (zh) | 一种治疗高血压的药物组合物 | |
US20150079183A1 (en) | Lercanidipine Hydrochloride and Losartan Potassium Compound Preparation and Preparation Method Thereof | |
CN103386130A (zh) | Ace抑制剂/噻嗪类利尿剂/5-甲基四氢叶酸药物组合物及用途 | |
CN102362865B (zh) | 一种含有盐酸贝尼地平和缬沙坦的复方制剂及其应用 | |
CN102485228B (zh) | 一种药物组合物及其用途 | |
CN102370965A (zh) | 一种含有左旋氨氯地平药学上可接受的盐与培哚普利药学上可接受的盐的药物组合物 | |
CN101416966A (zh) | 一种治疗高血压的药物组合物 | |
CN101198326B (zh) | Ⅱ型糖尿病治疗用的组合药物制剂 | |
CN102397278A (zh) | 一种抗高血压药物组合物 | |
US10463622B2 (en) | Treatments and formulations comprising Torsemide | |
CN102058591A (zh) | 一种左旋氨氯地平和替米沙坦的复方制剂 | |
CN102379875A (zh) | 一种含有盐酸贝尼地平和酒石酸美托洛尔的复方制剂及其应用 | |
CN102485227B (zh) | 一种药物组合物及其用途 | |
CN110755390A (zh) | 复方降压药物片剂及其用途 | |
CN103272236B (zh) | 含有β-肾上腺素受体阻滞剂和B族维生素的药物组合物及其用途 | |
CN102389431A (zh) | 一种含有盐酸贝尼地平和盐酸贝那普利的复方制剂及其应用 | |
CN102579442B (zh) | 一种含有盐酸贝尼地平和阿托伐他汀钙的胶囊制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANDONG SIBANGDE PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHANDONG XINBAO PHARMACEUTICAL CO., LTD. Effective date: 20130418 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Xu Yan Inventor after: Yuan Wujie Inventor after: Chu Maozhong Inventor after: Wang Haohua Inventor after: Ma Quanlong Inventor before: Ma Quanlong Inventor before: Chu Maozhong Inventor before: Wang Haohua Inventor before: Xu Dongsheng Inventor before: Sun Shan Inventor before: Wang Shuyun Inventor before: Liang Haiyong |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250131 JINAN, SHANDONG PROVINCE TO: 250216 JINAN, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: MA QUANLONG CHU MAOZHONG WANG HAOHUA XU DONGSHENG SUN SHAN WANG SHUYUN LIANG HAIYONG TO: XU YAN YUAN WUJIE CHU MAOZHONG WANG HAOHUA MA QUANLONG |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130418 Address after: 250216, Longhu Road, Longshan Town, Ji'nan, Shandong, Zhangqiu Applicant after: Shandong Sibangde Pharmaceutical Co., Ltd. Address before: 250131 No. 143-9 industrial North Road, Licheng District, Shandong, Ji'nan Applicant before: Shandong Xinbao Pharmaceutical Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |